News summary
Boteng Shares: Currently, the U.S. Biosafety Act has not had a material impact on the company's orders and business operations. Securities Times e Company NewscrashtwinsanityandroidBoteng recently stated at a performance briefing that in the first quarter of this year, the company's North American market revenue accounted for approximately 30%. Currently, although the industry will be sensitive to American healthcrashtwinsanityandroid...
Newsletter text
Boteng Shares: Currently, the U.S. Biosafety Act has not had a substantial impact on the company's orders and business operations. Securities Times e Company News, Boteng Shares recently stated at a performance briefing that in the first quarter of this year, the company's North American market revenue accounted for approximately 30%. At present, although the industry will continue to pay attention to the progress of the U.S. Biosafety Act, it has not had a substantial impact on the company's orders and business operations.